UPDATE: Piper Jaffray Downgrades Onconova Therapeutics as Lead Indication Failure Raises Doubts on Rigo
UPDATE: Piper Jaffray Downgrades VIVUS Following Management Meetings
UPDATE: Piper Jaffray Upgrades Geron on Enhanced Imetelstat Confidence
UPDATE: Piper Jaffray Initiates Palatin Technologies at Overweight Following End of BMT Testing